Resveratrol and prednisolone loaded into human serum albumin nanoparticles for the alleviation of rheumatoid arthritis symptoms: an in vitro and in vivo study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Radu A-F, and Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11): 2857. doi: 10.3390/cells10112857RaduA-FBungauSG.Management of rheumatoid arthritis: an overview. . 2021;10(11): 2857. doi: 10.3390/cells10112857Open DOISearch in Google Scholar
Conigliaro P, et al. Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev. 2019;18(7):706–713. doi: 10.1016/j.autrev.2019.05.007ConigliaroPChallenges in the treatment of rheumatoid arthritis. . 2019;18(7):706–713. doi: 10.1016/j.autrev.2019.05.007Open DOISearch in Google Scholar
Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology. 2020;59(10):2661–2670. doi: 10.1093/rheumatology/keaa232DedmonLE.The genetics of rheumatoid arthritis. . 2020;59(10):2661–2670. doi: 10.1093/rheumatology/keaa232Open DOISearch in Google Scholar
Nguyen TT, et al. Nanotechnology-based drug delivery for central nervous system disorders. Biomed Pharmacother. 2021;143:112117. doi: 10.1016/j.biopha.2021.112117NguyenTTNanotechnology-based drug delivery for central nervous system disorders. . 2021;143:112117. doi: 10.1016/j.biopha.2021.112117Open DOISearch in Google Scholar
Sim S, Wong NK. Nanotechnology and its use in imaging and drug delivery. Biomed Rep. 2021;14(5):1–9. doi: 10.3892/br.2021.1418SimSWongNK.Nanotechnology and its use in imaging and drug delivery. . 2021;14(5):1–9. doi: 10.3892/br.2021.1418Open DOISearch in Google Scholar
Shaito A, et al. Potential adverse effects of resveratrol: A literature review. Int J Mol Sci. 2020;21(6):2084. doi: 10.3390/ijms21062084ShaitoAPotential adverse effects of resveratrol: A literature review. . 2020;21(6):2084. doi: 10.3390/ijms21062084Open DOISearch in Google Scholar
Albano GD, et al. Adverse effects of anabolic-androgenic steroids: A literature review. Healthcare. 2021. doi: 10.3390/healthcare9010097AlbanoGDAdverse effects of anabolic-androgenic steroids: A literature review. . 2021. doi: 10.3390/healthcare9010097Open DOISearch in Google Scholar
Parsamanesh N, et al. Resveratrol and endothelial function: A literature review. Pharmacol Res. 2021;170:105725. doi: 10.1016/j.phrs.2021.105725ParsamaneshNResveratrol and endothelial function: A literature review. . 2021;170:105725. doi: 10.1016/j.phrs.2021.105725Open DOISearch in Google Scholar
Malviya V, et al. A brief review on resveratrol. 2022. doi: 10.52711/2231-5659.2022.00027MalviyaV. 2022. doi: 10.52711/2231-5659.2022.00027Open DOISearch in Google Scholar
Delmas D, et al. New highlights of resveratrol: A review of properties against ocular diseases. Int J Mol Sci. 2021;22(3):1295. doi: 10.3390/ijms22031295DelmasDNew highlights of resveratrol: A review of properties against ocular diseases. . 2021;22(3):1295. doi: 10.3390/ijms22031295Open DOISearch in Google Scholar
Sheng S, et al. The role of resveratrol on rheumatoid arthritis: From bench to bedside. Front Pharmacol. 2022;13:829677. doi: 10.3389/fphar.2022.829677ShengSThe role of resveratrol on rheumatoid arthritis: From bench to bedside. . 2022;13:829677. doi: 10.3389/fphar.2022.829677Open DOISearch in Google Scholar
Berardicurti O, et al. Glucocorticoids in rheumatoid arthritis: The silent companion in the therapeutic strategy. Expert Rev Clin Pharmacol. 2020;13(6):593–604. doi: 10.1080/17512433.2020.1772055BerardicurtiOGlucocorticoids in rheumatoid arthritis: The silent companion in the therapeutic strategy. . 2020;13(6):593–604. doi: 10.1080/17512433.2020.1772055Open DOISearch in Google Scholar
De Andrade J, McCormick J, Hill A. Small doses of prednisolone in the management of rheumatoid arthritis. Ann Rheum Dis. 1964;23(2):158. doi: 10.1136/ard.23.2.158De AndradeJMcCormickJHillA.Small doses of prednisolone in the management of rheumatoid arthritis. . 1964;23(2):158. doi: 10.1136/ard.23.2.158Open DOISearch in Google Scholar
Ethgen O, et al. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opin. 2013;29(9):1147–1160. doi: 10.1185/03007995.2013.818531EthgenOWhat do we know about the safety of corticosteroids in rheumatoid arthritis?. 2013;29(9):1147–1160. doi: 10.1185/03007995.2013.818531Open DOISearch in Google Scholar
Viscido A, et al. Nanotechnology in the treatment of inflammatory bowel diseases. J Crohns Colitis. 2014;8(9):903–918. doi: 10.1016/j.crohns.2014.02.024ViscidoANanotechnology in the treatment of inflammatory bowel diseases. . 2014;8(9):903–918. doi: 10.1016/j.crohns.2014.02.024Open DOISearch in Google Scholar
Kianfar E, et al. Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles. J Nanobiotechnol. 2021;19(1):159. doi: 10.1186/s12951-021-00896-3KianfarEProtein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles. . 2021;19(1):159. doi: 10.1186/s12951-021-00896-3Open DOISearch in Google Scholar
Meng R, et al. Preparation of drug-loaded albumin nanoparticles and its application in cancer therapy. J Nanomater. 2022;2022:1–12. doi: 10.1155/2022/305 2175MengRPreparation of drug-loaded albumin nanoparticles and its application in cancer therapy. . 2022;2022:1–12. doi: 10.1155/2022/305 2175Open DOISearch in Google Scholar
Solanki R, Patel K, Patel S. Bovine serum albumin nanoparticles for the efficient delivery of berberine: Preparation, characterization and in vitro biological studies. Colloids Surf A Physicochem Eng Asp. 2021;608:125501. doi: 10.1016/j.colsurfa.2020.125501SolankiRPatelKPatelS.Bovine serum albumin nanoparticles for the efficient delivery of berberine: Preparation, characterization and in vitro biological studies. . 2021;608:125501. doi: 10.1016/j.colsurfa.2020.125501Open DOISearch in Google Scholar
Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. doi: 10.1038/s41573-020-0090-8MitchellMJEngineering precision nanoparticles for drug delivery. . 2021;20(2):101–124. doi: 10.1038/s41573-020-0090-8Open DOISearch in Google Scholar
Begines B, et al. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials. 2020;10(7):1403. doi: 10.3390/nano1071403BeginesBPolymeric nanoparticles for drug delivery: Recent developments and future prospects. . 2020;10(7):1403. doi: 10.3390/nano1071403Open DOISearch in Google Scholar
Liu R, et al. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Lett. 2023;34(2):107518. doi: 10.1016/j.cclet.2022.05. 032LiuRAdvances of nanoparticles as drug delivery systems for disease diagnosis and treatment. . 2023;34(2):107518. doi: 10.1016/j.cclet.2022.05. 032Open DOISearch in Google Scholar
Amighi F, Emam-Djomeh Z, Labbafi-Mazraeh-Shahi M. Effect of different cross-linking agents on the preparation of bovine serum albumin nanoparticles. J Iranian Chem Soc. 2020;17:1223–1235. doi: 10.1007/s13738-0 19-01850-9AmighiFEmam-DjomehZLabbafi-Mazraeh-ShahiM.Effect of different cross-linking agents on the preparation of bovine serum albumin nanoparticles. . 2020;17:1223–1235. doi: 10.1007/s13738-0 19-01850-9Open DOISearch in Google Scholar
Solanki R, et al. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. Int J Biol Macromol. 2021;193:528–540. doi: 10.1016/j.ijbiomac.2021.10.040SolankiRAnticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. . 2021;193:528–540. doi: 10.1016/j.ijbiomac.2021.10.040Open DOISearch in Google Scholar
Hornok V. Serum albumin nanoparticles: Problems and prospects. Polymers. 2021;13(21):3759. doi: 10.3390/po lym13213759HornokV.Serum albumin nanoparticles: Problems and prospects. . 2021;13(21):3759. doi: 10.3390/po lym13213759Open DOISearch in Google Scholar
Gaballa SA, et al. Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11:866–893. doi: 10.1007/s13346-020-00843-zGaballaSACorticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives. . 2021;11:866–893. doi: 10.1007/s13346-020-00843-zOpen DOISearch in Google Scholar
Meng T, et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules. 2021;26(1):229. doi: 10.3390/molecules26010229MengTAnti-inflammatory action and mechanisms of resveratrol. . 2021;26(1):229. doi: 10.3390/molecules26010229Open DOISearch in Google Scholar
Chamundeeswari M, Jeslin J, Verma ML. Nanocarriers for drug delivery applications. Environ Chem Lett. 2019;17:849–865. doi: 10.1007/s10311-018-00841-1ChamundeeswariMJeslinJVermaML.Nanocarriers for drug delivery applications. . 2019;17:849–865. doi: 10.1007/s10311-018-00841-1Open DOISearch in Google Scholar
Morselli E, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010;1(1):e10. doi: 10.1038/cddis.2009.8MorselliECaloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. . 2010;1(1):e10. doi: 10.1038/cddis.2009.8Open DOISearch in Google Scholar
Peng Y, et al. Glucocorticoids disrupt skeletal angiogenesis through transrepression of NF-κB–Mediated preosteoclast pdgfb transcription in young mice. J Bone Miner Res. 2020;35(6):1188–1202. doi: 10.1002/jbmr.3987PengYGlucocorticoids disrupt skeletal angiogenesis through transrepression of NF-κB–Mediated preosteoclast pdgfb transcription in young mice. . 2020;35(6):1188–1202. doi: 10.1002/jbmr.3987Open DOISearch in Google Scholar
Matthay MA, Wick KD. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome. J Clin Invest. 2020;130(12):6218–6221. doi: 10.1172/JC I143331MatthayMAWickKD.Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome. . 2020;130(12):6218–6221. doi: 10.1172/JC I143331Open DOISearch in Google Scholar